【科技日报】临床植入式电极精准定位脑深部肿瘤边界

Core Insights - The clinical trial conducted by the Aerospace Information Innovation Research Institute and Harbin Medical University is the first in the world to apply brain-machine interface technology for precise boundary localization of deep brain tumors during surgery [1][2] - The trial utilized the NeuroDepth microelectrode and the AIRCAS-128 device, enabling real-time detection and analysis of neural signals, which aids in accurate tumor boundary identification [1][2] Group 1 - The clinical trial represents a significant breakthrough in domestically developed implantable clinical brain-machine interface technology [1] - The NeuroDepth microelectrode can detect signals from various brain regions, including deep brain areas, overcoming the limitations of traditional electrodes [1] - The technology allows for simultaneous detection of chemical signals, providing comprehensive data to differentiate between tumor and normal tissue [1] Group 2 - The trial was conducted on a glioma patient who experienced frequent seizures due to tumor pressure, and it successfully identified tumor boundaries while preserving functional areas [2] - The success of this clinical trial marks a critical step towards the clinical translation and industrialization of brain-machine interface technology [2]